NYSE: Corporate Board Member Online
Mitigating the Risks of Stockholder Litigation in M&A Transactions
July 31, 2015
The statistics are remarkable. Virtually every merger transaction nowadays involving a public company will be the subject of stockholder litigation. That is true regardless of the size of the deal, the size of the premium, the form of the transaction, the identity of the parties or the care with which the board proceeded. Often, plaintiffs' firms announce “investigations” of transactions within a matter of hours of the announcement of a transaction—and sometimes within minutes. Given the near certainty that your deal will be the subject of litigation, this article provides a few common sense ways to mitigate exposure and to ensure that the inevitable lawsuits result in minimal disruption.
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Telix Pharmaceutical in US$2.1 Billion Partnering Agreement With RegeneronApril 13, 2026Industrial Accelerator Act: A New Framework for EU (Sustainable) Industrial GrowthApril 9, 2026Sidley Represents Axsome Therapeutics in its Acquisition of Global Rights to Balipodect from TakedaApril 3, 2026Sidley Advising Macquarie Asset Management on ₹150 Billion Sale of Safeway Concessions Toll Road Portfolio in India to VINCIApril 2, 2026Nineteen Sidley Lawyers Named Finalists for the Women in Business Law Americas Awards 2026April 2, 2026Sidley Represents New Height Energy in Acquisition Financing of Midland Basin AssetsApril 2, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
